Device Cardiac Arrhythmia Monitoring

Hillrom - Carnation Ambulatory Monitor

Payments companies reported to CMS as associated with Hillrom - Carnation Ambulatory Monitor. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$435Kassociated payments (2023-2025)
4,143clinicians with associated payments
1company reporting

By year

2023 $101K
2024 $136K
2025 $197K

Payments reported as associated with Hillrom - Carnation Ambulatory Monitor, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Cardiovascular Disease $165K
Clinical Cardiac Electrophysiology $161K
Interventional Cardiology $24K
Family $17K
Internal Medicine $11K
Family Medicine $9,900

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Hillrom - Carnation Ambulatory Monitor

These are the largest totals companies reported as associated with Hillrom - Carnation Ambulatory Monitor. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Susan Eisenberg Saint Helena, CA Clinical Cardiac Electrophysiology $85,848.12
Christopher Lavergne The Woodlands, TX Cardiovascular Disease $59,000.00
Jason Garlie Coon Rapids, MN Cardiovascular Disease $40,000.00
Steven Kutalek Langhorne, PA Clinical Cardiac Electrophysiology $36,000.00
Samer Ajam Hobart, IN Clinical Cardiac Electrophysiology $13,983.50
Jonas Cooper Chesterfield, MO Clinical Cardiac Electrophysiology $7,704.91
Aditya Sharma Carlisle, PA Interventional Cardiology $514.02
Zohair Raza Pasadena, TX Cardiovascular Disease $437.35
Ahtisham Shakoor Chandler, AZ Cardiovascular Disease $354.39
Majdi Ashchi Jacksonville, FL Cardiovascular Disease $351.02

Prescribed Hillrom - Carnation Ambulatory Monitor?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.